Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLong-Term Debt RepaymentsNon-Current ReceivablesReceivables RefundsShares Issued
Ratios

Ascendis Pharma A (ASND) Depreciation & Amortization (IS) (2016 - 2019)

Historic Depreciation & Amortization (IS) for Ascendis Pharma A (ASND) over the last 6 years, with Q2 2019 value amounting to $1.7 million.

  • Ascendis Pharma A's Depreciation & Amortization (IS) rose 61157.3% to $1.7 million in Q2 2019 from the same period last year, while for Jun 2019 it was $3.7 million, marking a year-over-year increase of 29838.91%. This contributed to the annual value of $11.3 million for FY2020, which is 5214.48% up from last year.
  • According to the latest figures from Q2 2019, Ascendis Pharma A's Depreciation & Amortization (IS) is $1.7 million, which was up 61157.3% from $1.5 million recorded in Q1 2019.
  • Over the past 5 years, Ascendis Pharma A's Depreciation & Amortization (IS) peaked at $1.7 million during Q2 2019, and registered a low of $138969.4 during Q1 2015.
  • In the last 5 years, Ascendis Pharma A's Depreciation & Amortization (IS) had a median value of $196693.6 in 2016 and averaged $355551.8.
  • As far as peak fluctuations go, Ascendis Pharma A's Depreciation & Amortization (IS) tumbled by 1478.11% in 2015, and later soared by 61157.3% in 2019.
  • Over the past 5 years, Ascendis Pharma A's Depreciation & Amortization (IS) (Quarter) stood at $167705.9 in 2015, then increased by 11.38% to $186792.3 in 2016, then increased by 24.18% to $231954.2 in 2017, then rose by 22.53% to $284207.7 in 2018, then skyrocketed by 494.62% to $1.7 million in 2019.
  • Its Depreciation & Amortization (IS) stands at $1.7 million for Q2 2019, versus $1.5 million for Q1 2019 and $284207.7 for Q4 2018.